Phase II study of Docetaxel and Cisplatin in a circadian timing as first line chemotherapy (CT) in advanced non small cell lung cancer (NSCLC)

被引：7
|
作者：
Faderl, B
von Pawel, J
Wagner, H
Krauss, C
Achterrath, W
机构：
[1] Asklepios Fachkliniken, Munich, Germany
[2] Rhone Poulenc Rorer, Cologne, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81437-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1017
引用
收藏
页码：S256 / S256
页数：1
相关论文
共 50 条
  • [1] Phase II study of docetaxel and cisplatin in a circadian timing as first line chemotherapy (CT) in advanced non small cell lung cancer (NSCLC)
    Faderl, B
    von Pawel, J
    Wagner, H
    Krauss, C
    Achterrath, W
    ANNALS OF ONCOLOGY, 1998, 9 : 89 - 89
  • [2] Phase II trial of weekly docetaxel and carboplatin as first line chemotherapy in advanced or metastatic non small cell lung cancer (NSCLC).
    Chahine, GY
    Nasr, FL
    Kattan, JG
    Farhat, FS
    El Seoudi, ME
    Bachour, M
    Moukadem, WT
    Younes, FC
    Ghosn, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 702S - 702S
  • [3] SECOND-LINE CHEMOTHERAPY (CT) WITH DOCETAXEL IN ELDERLY ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS: A PHASE II STUDY
    Bernardini, I.
    Tibaldi, C.
    Chella, A.
    Galli, L.
    Russo, F.
    Toma, G.
    Tempestini, F.
    Santolicandro, A. M.
    Coltelli, L.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2004, 15 : 34 - 34
  • [4] First Line Chemotherapy with Weekly Docetaxel and Cisplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer A Multicenter Phase II Study
    Han, Keqi
    Cao, Weiguo
    Che, Jinfeng
    Bo, Shenxu
    Guo, Xiaodong
    Huang, Guang
    Ma, Lijun
    Sun, Liangqi
    Gao, Chunfang
    Zhong, Baoliang
    Cao, Zhigang
    Tucker, Steven Jay
    Wang, Daoyuan
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 512 - 517
  • [5] First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: A multicenter phase II study
    Georgoulias, V
    Androulakis, N
    Dimopoulos, AM
    Kourousis, C
    Kakolyris, S
    Papadakis, E
    Apostolopoulou, F
    Papadimitriou, C
    Vossos, A
    Agelidou, M
    Heras, P
    Tzannes, S
    Vlachonicolis, J
    Mavromanolakis, E
    Hatzidaki, D
    ANNALS OF ONCOLOGY, 1998, 9 (03) : 331 - 334
  • [6] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Biweekly docetaxel and carboplatin ase first line chemotherapy in advanced non small cell lung cancer (NSCLC)
    Firvida, Jose L.
    Esquerdo, Gaspar
    Amenedo, Margarita
    Salgado, Mercedes
    Llorca, Cristina
    Ramos, Manuel
    Perez, Eva
    Cervera, Jose M.
    Gomez, Jesus Garcia
    Mata, Jesus Garcia
    ANNALS OF ONCOLOGY, 2006, 17 : 224 - 225
  • [8] Biweekly docetaxel and gemcitabine as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Gaspar, E.
    Firvida, J.
    Amenedo, M.
    Orts, D.
    Salgado, M.
    LLorca, C.
    Ramos, M.
    Perez, E.
    Cervera, J.
    Abal, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer
    Zalcberg, J
    Millward, M
    Bishop, J
    McKeage, M
    Zimet, A
    Toner, G
    Friedlander, M
    Barter, C
    Rischin, D
    Loret, C
    James, R
    Bougon, N
    Berille, J
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1948 - 1953
  • [10] Cisplatin and weekly docetaxel as first-line therapy in patients with advanced non-small cell lung cancer a phase II study
    Tartarone, A
    Romano, G
    Iodice, G
    Capobianco, A
    Coccaro, M
    Bochicchio, A
    Di Leo, P
    Ardito, R
    Di Renzo, N
    TUMORI, 2005, 91 (02) : 131 - 134
12345